Vivo Capital

Vivo Capital as of June 30, 2026

Portfolio Holdings for Vivo Capital

Vivo Capital holds 47 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Trevi Therapeutics Common (TRVI) 8.7 $95M 5.1M 18.65
Praxis Precision Medicines Common (PRAX) 8.3 $91M 271k 334.79
Erasca Common (ERAS) 6.9 $76M 4.1M 18.32
Arrivent BioPharma Common (AVBP) 5.3 $58M 1.7M 34.74
Abivax SA - Sponsored Ads (ABVX) 5.0 $55M 415k 133.26
Tango Therapeutics Common (TNGX) 3.9 $43M 1.4M 31.26
Corvus Pharmaceuticals Common (CRVS) 3.8 $42M 2.8M 14.94
Bright Minds Biosciences Common (DRUG) 3.6 $39M 557k 70.20
Sinovac Biotech SHS 3.5 $38M 5.9M 6.47
Tenax Therapeutics Common (TENX) 3.3 $36M 2.5M 14.55
Aclaris Therapeutics Common (ACRS) 3.2 $35M 6.7M 5.29
Dyne Therapeutics Common (DYN) 3.2 $35M 1.6M 22.21
Dianthus Therapeutics Common (DNTH) 3.2 $35M 354k 97.48
Alto Neuroscience Common (ANRO) 2.9 $32M 1.2M 26.39
DBV Technologies SA Sponsored Ads (DBVT) 2.8 $30M 1.8M 16.40
SAB Biotherapeutics Common (SABS) 2.6 $29M 7.3M 3.90
Moonlake Immunotherapeutics Class A ORD (MLTX) 2.5 $27M 1.4M 19.47
LB Pharmaceuticals Common (LBRX) 2.4 $26M 800k 32.45
Minerva Neurosciences Common (NERV) 2.2 $24M 4.3M 5.55
Design Therapeutics Common (DSGN) 2.1 $23M 1.6M 14.47
Oric Pharmaceuticals Common (ORIC) 1.8 $20M 1.8M 10.83
CAMP4 Therapeutics Corporation Common (CAMP) 1.7 $19M 4.2M 4.37
Faeth Therapeutics Common (FTH) 1.6 $18M 722k 25.00
Achieve Life Sciences Common (ACHV) 1.6 $18M 2.8M 6.53
Compass Therapeutics Common (CMPX) 1.6 $17M 7.8M 2.19
AN2 Therapeutics Common (ANTX) 1.4 $15M 3.2M 4.84
Editas Medicine Common (EDIT) 1.1 $12M 3.6M 3.24
Geron Corp Common (GERN) 1.0 $11M 8.7M 1.28
Odyssey Therapeutics Common 1.0 $11M 575k 18.71
Eupraxia Pharmaceuticals Common (EPRX) 0.8 $8.9M 1.4M 6.61
Onkure Therapeutics Common (OKUR) 0.8 $8.8M 1.9M 4.56
Olema Pharmaceuticals Common (OLMA) 0.8 $8.4M 672k 12.51
Monopar Therapeutics Common (MNPR) 0.8 $8.4M 91k 92.59
Aura Biosciences Common (AURA) 0.8 $8.3M 1.2M 7.10
Surrozen Common (SRZN) 0.6 $6.7M 260k 25.95
ALX Oncology Holdings Common (ALXO) 0.6 $6.6M 3.2M 2.07
Satellos Bioscience Common (MSLE) 0.6 $6.3M 814k 7.78
Avalo Therapeutics Common (AVTX) 0.5 $5.1M 275k 18.48
Pepgen Common (PEPG) 0.4 $4.2M 2.3M 1.80
Valneva SE Sponsored Ads (VALN) 0.4 $4.0M 763k 5.23
Sera Prognostics Common (SERA) 0.3 $3.0M 1.7M 1.82
Unicycive Therapeutics Common (UNCY) 0.2 $2.6M 550k 4.69
Instil Bio Common (TIL) 0.2 $2.3M 293k 7.69
InMed Pharmaceuticals Common (INM) 0.1 $1.2M 798k 1.55
Bolt Biotherapeutics Common (BOLT) 0.0 $279k 72k 3.85
Pasithea Therapeutics Corp Common (KTTA) 0.0 $240k 466k 0.52
Precision Biosciences Common (DTIL) 0.0 $37k 4.7k 7.86